FPIN's Clinical Inquiries
From the Family Practice Inquiries Network

SBIRT for Alcohol Use in Adolescents

Katherine Bergs, PhD, LMFT
Adam Guck, PhD, ABPP
Jesse Kao, MD
Morgan Fields, MD
Andrew Maxwell, MD

American Family Physician. 2024;110(2):197-198.

Author disclosure: No relevant financial relationships.

CLINICAL QUESTION

Is SBIRT (i.e., screening, brief intervention, and referral to treatment) effective for reducing alcohol use in adolescents?

EVIDENCE-BASED ANSWER

It is unclear how effective SBIRT is for reducing alcohol use in adolescents. Elements of SBIRT, including a brief intervention alone with no screening or referral to treatment, may reduce alcohol consumption and alcohol-related consequences in adolescents. (Strength of Recommendation [SOR]: A, systematic review of randomized controlled trials [RCTs].) The use of elements of SBIRT (i.e., brief intervention only or screening plus brief intervention) may reduce alcohol consumption in adolescents with heavy alcohol use at baseline. (SOR: B, RCT.) The use of SBIRT does not reduce alcohol use over 6 to 24 months but may decrease the diagnosis of alcohol use disorder in adolescents over a 7-year follow-up. (SOR: B, RCTs.)

EVIDENCE SUMMARY

A 2022 systematic review examined the effects of brief interventions on substance use and internalizing symptoms (e.g., depression/anxiety) in adolescents.1 Participants were between 13 and 21 years of age and had a brief psychosocial intervention, a comparison condition, and at least one treatment outcome evaluating mental health and one treatment outcome evaluating substance use. Six studies met inclusion criteria (n = 2,380 in treatment conditions; n = 1,422 in control groups).

Modalities varied and included brief interventions and motivational interviewing, relaxation training, cognitive behavior therapy, and telephone- and computer-delivered feedback. Interventions ranged from 15 to 240 minutes, comprising one to four sessions over periods ranging from a minimum of 1 day to a maximum of 12 weeks. Five studies used treatment-as-usual control groups; one study used an attention control group. Follow-up periods ranged from 12 weeks to 3 years across the six studies and used self-report measures, including the Daily Drinking Questionnaire, the Young Adult Alcohol Consequences Questionnaire, and reported drinks per week or onset/frequency of binge drinking. In five of the six studies, authors reported significant reductions in self-reported daily drinking or alcohol-related consequences. The findings of two studies (n = 1,210; n = 151) could not be independently confirmed; therefore, the effect size was not reported. One RCT (n = 393) showed one brief intervention condition reduced substance use and substance use–related consequences at the first follow-up only (effect sizes = 3.6 and 0.52, respectively; CIs not reported), and one brief intervention condition reduced substance use and substance use–related consequences at the first follow-up (effect sizes = 0.62 and 0.29, respectively) and the last follow-up (effect sizes = 0.60 and 0.34, respectively).

One RCT (n = 104) showed a significant reduction in drinks per week and drinking days per week at the first follow-up (effect sizes = 0.99 and 0.76, respectively) but not at the last follow-up. Another RCT (n = 1,871) showed a reduction in substance use diagnoses following brief intervention at the 3-year follow-up (effect size = 0.29) but not at the first follow-up. The final RCT (n = 73) did not show a significant independently confirmed treatment effect for telephone-delivered feedback intervention. The authors noted that high variability in the type of intervention limited the generalizability of the findings, and that the treatment effect was inconsistent across follow-up intervals. This systematic review examined only the brief intervention element of SBIRT and lacked the screening and referral-to-treatment components. The brief interventions reviewed were not delivered in a health care setting (e.g., primary care, emergency department), which is generally considered a point of emphasis for SBIRT.

KATHERINE BERGS, PhD, LMFT, is a psychologist and faculty member at JPS Family Medicine Residency Program, Fort Worth, Texas

ADAM GUCK, PhD, ABPP, is a psychologist and faculty member at JPS Family Medicine Residency Program, Fort Worth, Texas

JESSE KAO, MD, is a resident at JPS Family Medicine Residency Program, Fort Worth, Texas

MORGAN FIELDS, MD, is a resident at JPS Family Medicine Residency Program, Fort Worth, Texas

ANDREW MAXWELL, MD, is a resident at JPS Family Medicine Residency Program, Fort Worth, Texas

Address correspondence to Katherine Bergs, PhD, LMFT, at kbergs@jpshealth.org.

Author disclosure: No relevant financial relationships.

  1. 1.McDanal R, Parisi D, Opara I, et al. Effects of brief interventions on internalizing symptoms and substance use in youth: a systematic review. Clin Child Fam Psychol Rev. 2022;25(2):339-355.
  2. 2.D’Amico EJ, Parast L, Osilla KC, et al. Understanding which teenagers benefit most from a brief primary care substance use intervention. Pediatrics. 2019;144(2):e20183014.
  3. 3.Sterling S, Kline-Simon AH, Weisner C, et al. Pediatrician and behavioral clinician–delivered screening, brief intervention and referral to treatment: substance use and depression outcomes. J Adolesc Health. 2018;62(4):390-396.
  4. 4.Sterling S, Parthasarathy S, Jones A, et al. Young adult substance use and healthcare use associated with screening, brief intervention and referral to treatment in pediatric primary care. J Adolesc Health. 2022;71(4 S):S15-S23.
  5. 5.Levy SJL, Williams JF; Committee on Substance Use and Prevention. Substance use screening, brief intervention, and referral to treatment. Pediatrics. 2016;138(1):e20161211.
  6. 6.Krist AH, Davidson KW, Mangione CM, et al. Screening for unhealthy drug use: U.S. Preventive Services Task Force recommendation statement. JAMA. 2020;323(22):2301-2309.

Clinical Inquiries provides answers to questions submitted by practicing family physicians to the Family Physicians Inquiries Network (FPIN). Members of the network select questions based on their relevance to family medicine. Answers are drawn from an approved set of evidence-based resources and undergo peer review. The strength of recommendations and the level of evidence for individual studies are rated using criteria developed by the Evidence-Based Medicine Working Group (https://www.cebm.net).

The complete database of evidence-based questions and answers is copyrighted by FPIN. If interested in submitting questions or writing answers for this series, go to https://www.fpin.org or email questions@fpin.org.

Copyright © Family Physicians Inquiries Network. Used with permission.

This series is coordinated by John E. Delzell Jr., MD, MSPH, associate medical editor.

A collection of FPIN’s Clinical Inquiries published in AFP is available at https://www.aafp.org/afp/fpin.

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.